Stage 1 melanoma is treatable with surgery, and when combined with early detection, proper care and regular follow-ups, it offers a favorable outlook. Stage 1 melanoma is treatable with surgery, and ...

Melanoma stages range from 0, localized, to 4, metastatic. Early melanoma diagnosis and treatment improve survival chances significantly, with 98.4% for stages 0-2. Melanoma is a severe type of skin ...

Melanoma in situ (MIS), also called stage 0 melanoma, is the earliest stage of melanoma, when the cancer is confined to the outermost layer of skin. Most melanomas affect the skin, but they can also ...

The study aimed to improve the understanding of lived experiences and the fear of recurrence among survivors of localized, stage 0 to IIA cutaneous melanoma. A qualitative study found most survivors ...

About 10% of adolescents and young adults treated for solid tumors have a metastatic recurrence, with 5-year rates surpassing ...

Opdivo is a programmed death receptor-1 (PD-1) blocking antibody. The Food and Drug Administration (FDA) has expanded the approval of Opdivo ® (nivolumab) to include adjuvant treatment of patients 12 ...

RP1 and nivolumab combination achieved a 32.9% objective response rate and 15.0% complete response rate in advanced melanoma patients post anti–PD-1 therapy failure. The treatment demonstrated durable ...

The idea that patients could get better responses with shorter courses of therapy runs counter to the current standard of care in melanoma. Giving patients with resectable stage III melanoma a ...

An academic randomized trial undertaken in patients with anti–PD-1 refractory melanoma demonstrated more than a doubling of PFS (7.2 v 3.1 months, hazard ratio [HR], 0.50, P < .001) with TILs compared ...